SLGL Sol-Gel Technologies Ltd.

Nasdaq sol-gel.com


$ 35.42 $ 0.00 (0 %)    

Tuesday, 18-Nov-2025 10:05:54 EST
QQQ $ 599.78 $ 0.16 (0.03 %)
DIA $ 463.05 $ 0.89 (0.19 %)
SPY $ 663.44 $ 1.32 (0.2 %)
TLT $ 88.93 $ -0.42 (-0.47 %)
GLD $ 374.75 $ -0.12 (-0.03 %)
$ 36
$ 36.00
$ 33.92 x 1
$ 35.50 x 100
-- - --
$ 4.01 - $ 52.26
8,487
na
100.29M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-sol-gel-technologies-raises-price-target-to-50

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Sol-Gel Technologies (NASDAQ:SLGL) with a Buy and raises the pr...

 sol-gel-technologies-q2-eps-417-beats-007-estimate-sales-17261m-beat-2900m-estimate

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly earnings of $4.17 per share which beat the analyst consensus estimate of ...

 sol-gel-technologies-q1-eps-320-vs-230-prior-year-sales-103m-miss-120m-estimate

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(3.20) per share. This is a 39.13 percent decrease over losses...

 sol-gel-announces-product-purchase-agreement-with-mayne-pharmas-unit-for-sale-and-exclusive-license-of-us-rights-to-epsolay-and-twyneo-sol-gel-to-receive-16m-during-2025

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to ...

 sol-gel-technologies-q3-eps-001-beats-013-estimate-sales-536m-beat-269m-estimate

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of ...

 raymond-james-downgrades-sol-gel-technologies-to-outperform-lowers-price-target-to-4

Raymond James analyst Elliot Wilbur downgrades Sol-Gel Technologies (NASDAQ:SLGL) from Strong Buy to Outperform and lowers t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION